These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30012300)

  • 21. Skin graft loss resulting from collagenase clostridium histolyticum treatment of Dupuytren contracture: case report and review of the literature.
    Swanson JW; Watt AJ; Vedder NB
    J Hand Surg Am; 2013 Mar; 38(3):548-51. PubMed ID: 23391354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications after treating Dupuytren's disease. A systematic literature review.
    Krefter C; Marks M; Hensler S; Herren DB; Calcagni M
    Hand Surg Rehabil; 2017 Oct; 36(5):322-329. PubMed ID: 28917432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Zhang P; Qin L
    N Engl J Med; 2009 Dec; 361(26):2578-9; author reply 2579-80. PubMed ID: 20032329
    [No Abstract]   [Full Text] [Related]  

  • 24. Dupuytren Disease Management Trends: A Survey of Hand Surgeons.
    Paynter JA; Tobin V; Rozen WM; Hunter-Smith DJ
    J Hand Surg Asian Pac Vol; 2020 Dec; 25(4):453-461. PubMed ID: 33115367
    [No Abstract]   [Full Text] [Related]  

  • 25. [Surgical treatment of Dupuytren contracture].
    Hahn P; Unglaub F
    Oper Orthop Traumatol; 2016 Feb; 28(1):2-3. PubMed ID: 26184721
    [No Abstract]   [Full Text] [Related]  

  • 26. [Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].
    Holzer LA; Holzer G
    Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):269-74. PubMed ID: 21935843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Tursi JP; Cohen B; Kaufman GJ; Lindau T
    J Hand Surg Am; 2013 Jan; 38(1):12-22. PubMed ID: 23200951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in dupuytren contracture: combined analysis of 4 phase 3 clinical trials.
    Badalamente MA; Hurst LC; Benhaim P; Cohen BM
    J Hand Surg Am; 2015 May; 40(5):975-83. PubMed ID: 25843533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using Tongue Depressors as a Technique to Aid Cord Localization During Collagenase Injection For Dupuytren Disease.
    Mehdi SK; Yonz MC; Keshtvarz S; Kamineni S; Dhawan V
    Tech Hand Up Extrem Surg; 2019 Dec; 23(4):196-198. PubMed ID: 31738740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease.
    Gilpin D; Coleman S; Hall S; Houston A; Karrasch J; Jones N
    J Hand Surg Am; 2010 Dec; 35(12):2027-38.e1. PubMed ID: 21134613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Collagenase Treatment for Dupuytren Disease.
    Badalamente MA; Hurst LC
    Hand Clin; 2018 Aug; 34(3):345-349. PubMed ID: 30012294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of Dupuytren's contracture by collagenase injection].
    Foissac R; Camuzard O; Dumas P; Dumontier C; Chignon-Sicard B
    Chir Main; 2013 Sep; 32(4):199-205. PubMed ID: 23856551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collagenase Clostridium histolyticum for the Treatment of Distal Interphalangeal Joint Contractures in Dupuytren Disease.
    Fei TT; Chernoff E; Monacco NA; Komatsu DE; Muhlrad S; Sampson SP; Hurst LC; Dagum AB
    J Hand Surg Am; 2019 May; 44(5):417.e1-417.e4. PubMed ID: 30146387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Collagenase Clostridium Histolyticum Injection with Precise Needle Length Adjusted by Silicone Tube Interposition for Dupuytren Contracture.
    Kanatani T; Nagura I; Harada Y
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):437-439. PubMed ID: 30282547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budget impact analysis in Spanish patients with Dupuytren's contracture: fasciectomy vs. collagenase Clostridium histolyticum.
    De Salas-Cansado M; Cuadros M; Del Cerro M; Arandes JM
    Chir Main; 2013 Apr; 32(2):68-73. PubMed ID: 23507313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin laceration as a serious adverse sequela of injectable collagenase for Dupuytren contracture.
    Hallock GG
    Plast Reconstr Surg; 2012 Jan; 129(1):205e-206e. PubMed ID: 22186568
    [No Abstract]   [Full Text] [Related]  

  • 37. New treatment option for Dupuytren's contracture.
    Mayo Clin Health Lett; 2010 Oct; 28(10):4. PubMed ID: 21033070
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for dupuytren contracture.
    Chen NC; Shauver MJ; Chung KC
    J Hand Surg Am; 2011 Nov; 36(11):1826-1834.e32. PubMed ID: 21981831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapies in Dupuytren Disease: Current and Novel Strategies.
    Lambi AG; Popoff SN; Benhaim P; Barbe MF
    J Hand Surg Am; 2023 Aug; 48(8):810-821. PubMed ID: 36935324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Management of Recurrent Dupuytren Contracture: A Systematic Review and Meta-analysis.
    Wong CR; Huynh MNQ; Fageeh R; McRae MC
    Hand (N Y); 2022 Nov; 17(6):1104-1113. PubMed ID: 33618538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.